Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Pricing
Privacy PolicyTerms of Service

ICCC

$9.91+0.76%

IMMUCELL CORP /DE/

Market Cap
$90M
Sector
Materials
Industry
Biotechnology
Beta
0.58
5yr monthly vs SPY
Price Chart
Loading…

Signals

Insider Velocity
24.0x
buying
Congress
—
recent trades
Short Volume
63%
W/W +42.6pp

Market & Alt Data

News
9
recent articles
Activist
13D
Knudsen
Analyst Consensus
Strong Buy
7 analysts
Velocity Score
23.98x
Current Rate (90d)
88.89/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
1
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-06-182026-06-22te Boekhorst Paul Francis OlivierDirector & President and CEOPurchase8,000$9.49$76K17.8KView

Recent News

ImmuCell (ICCC) Q2 2026 Earnings Call Transcript
Yahoo Finance · 2026-08-20
ImmuCell Corp (ICCC) (Q2 2026) Earnings Call Highlights: Record Net Income and Market Share ...
Yahoo Finance · 2026-08-14
ImmuCell Q2 Earnings Call Highlights
Yahoo Finance · 2026-08-14
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026
Yahoo Finance · 2026-08-13

Informational purposes only, not investment advice.

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026
Yahoo Finance · 2026-08-06
ImmuCell Posts Strong Preliminary Q2 Sales on U.S. Demand
Yahoo Finance · 2026-07-10
ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
Yahoo Finance · 2026-07-09
ICCC's Valuation Remains Premium: Is it Worth Overpaying for?
Yahoo Finance · 2026-06-18
Here’s Why ImmuCell Corporation (ICCC) is Emerging as an Intriguing Micro-Cap Opportunity
Yahoo Finance · 2026-05-13

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →